Global Health Limited has submitted its quarterly compliance certificate to stock exchanges for the quarter ended March 31, 2026. The certificate was filed under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, demonstrating the company's adherence to regulatory requirements.

Regulatory Compliance Filing

The company filed the certificate on April 02, 2026, with both major stock exchanges where its shares are listed. Company Secretary and Compliance Officer Rahul Ranjan submitted the documentation to BSE Limited and National Stock Exchange of India Limited.

Certificate Details

KFin Technologies Limited, serving as the company's Registrar and Transfer Agent, issued the certificates confirming compliance status. The certificates were addressed to both National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL).

Sharmila Hemant Amin, Assistant Vice President at KFin Technologies Limited, signed the certificates on behalf of the registrar. The certificates confirm that no securities dematerialization or rematerialization activities occurred during the quarter ended March 31, 2026.

Compliance Status

The certificate states that details of securities dematerialized or rematerialized during the quarter were nil. Consequently, no intimation was required to be made to depositories and stock exchanges as mandated under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018.

Corporate Information

Global Health Limited maintains its registered office at E-18, Medanta-Mediclinic, Defence Colony, New Delhi 110024. The company works with KFin Technologies Limited as its registrar and transfer agent, with operations centered in Hyderabad and registered office in Mumbai.

This quarterly filing represents part of the company's ongoing regulatory compliance obligations, ensuring transparency in share transfer and depository activities for stakeholders and regulatory authorities.

Global Health Limited has announced a scheduled virtual meeting with Permodalan Nasional Berhad (PNB), Malaysia, as part of its ongoing investor engagement activities. The meeting is organized under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

The company's management will participate in a structured investor interaction with the Malaysian institutional investor. The meeting details are as follows:

Regulatory Compliance

Global Health Limited has emphasized its commitment to regulatory compliance by ensuring that no unpublished price sensitive information will be shared during the meeting. This adherence to SEBI guidelines demonstrates the company's transparent approach to investor communications.

The company has also noted that the meeting schedule is subject to change in case of unforeseen circumstances on the part of analysts, investors, or the company itself. This flexibility clause provides necessary operational adaptability while maintaining professional commitment to stakeholder engagement.

Corporate Communication

The announcement was formally communicated to both BSE Limited and National Stock Exchange of India Limited through proper regulatory channels. Company Secretary and Compliance Officer Rahul Ranjan signed the official communication, ensuring proper corporate governance protocols were followed in the disclosure process.